Atnaujinkite slapukų nuostatas

El. knyga: Ethical Considerations When Preparing a Clinical Research Protocol

(Center for Ethics, Washington Hospital Center, Washington, DC, USA), (Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA), (National Institutes of Health, Bethesda, MD, USA)
  • Formatas: PDF+DRM
  • Išleidimo metai: 12-Jun-2020
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780123869548
  • Formatas: PDF+DRM
  • Išleidimo metai: 12-Jun-2020
  • Leidėjas: Academic Press Inc
  • Kalba: eng
  • ISBN-13: 9780123869548

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Ethical Considerations When Preparing a Clinical Research Protocol, Second Edition, provides a foundation for improving skills in the understanding of ethical requirements in the design and conduct of clinical research. It includes practical information on ethical principles in clinical research, how to design appropriate research studies, how to consent and assent documents, how to get protocols approved, special populations, confidentiality issues, and the reporting of adverse events. The book's valuable appendix includes a listing of web resources about research ethics, along with a glossary, making it an invaluable resource for scientists collaborating in clinical trials, physician investigators, clinical research fellows, and more.

  • Walks investigators and trainees through the identification of the ethical aspects of each section of a clinical research protocol
  • Includes case histories that illustrate key points
  • Contains information on conducting clinical research within the pharmaceutical industry
  • Includes internet resources and worldwide web addresses for important research ethics documents and regulations
  • Contains a chapter on Study Design and Methodology that is purposely expanded to explicitly address biostatistical considerations

Recenzijos

"It has been over 10 years since the initial edition of this text. This second edition serves as a more updated, comprehensive, cursory reference toward the ethical considerations necessary for developing and implementing clinical research studies. The publication's most important message is delivered in section A.2.3., yet, it is a thread throughout the book: knowing the basic ethical principles as well as regulations relevant to clinical research are not enough; rather, it takes mentoring, discussing, and resolving constructs and concerns through a team approach, which may be raised and delivered by a clinical research protocol. My criticism of the book is that there is an unsettling lack of attention to the clinical research ethical requirement of "respect for enrolled subjects" as originally published by Emanuel et al. in 2000. The application of this principle is to be realized in the study monitoring processes that maximize benefit and minimize risk; those processes being commensurate with the level of risk offered by the study design, intervention, and/or population and environment in which the protocol will be conducted, as well as the personnel by which it will be conducted. Of particular note is that this monitoring may (or may not) call for independent monitoring outside of the study team as well as Institutional Review Board (IRB). The material of the text appears to be limited to the concept of a Data and Safety Monitoring Board, which is only briefly mentioned and, as only a recent phenomenon, not so! While there are other publications that more fully address the ethical principle of "respect for enrolled subjects," it would be beneficial for this book to expound on this ethical principle and how it can be achieved during study conduct, as the book presents other ethical principle that are primarily applied during protocol development and initiation." --Doody

Review of the previous edition:"This book will be a very useful text and reference source for students and trainees at all levels, as well as for seasoned investigators and RERB members. The continuing proliferation of formal, degree-granting masters and doctoral training programs in clinical investigation at academic centers across the country underscores the need for a book like this. These programs, and the growing acceptance and recognition of professional certification programs for clinical research professionals, are indicators that the expectations we place on investigators are greater than they were just a few years ago. Recognition that good science and good ethics are inextricably bound together in clinical research is todays reality, and this book gives real insight into why and how." --JAMA, February 2006

Preface xi
Section A The basics: What you need to know before starting human participant research
1 Introduction to the ethics and science of clinical research
3(10)
1 Clinical research defined
3(1)
2 Clinical research ethics defined
3(1)
3 Oversight: Origins, the old regulations, and the revised common rule
4(2)
4 How to use this book
6(7)
2 What you need to know about clinical research ethics
13(18)
1 Intersections of scientific goals and ethical concerns: How study design influences evaluation of ethical considerations
13(4)
2 Landmark documents in the codification of clinical research ethics
17(4)
3 The basic principles and theories of clinical research ethics: Learning how to justify study design
21(7)
4 Balancing scientific efficiency against subject protection: Ensuring that the balance is always weighted in the right direction
28(3)
3 What you need to know about the regulation of clinical research
31(22)
1 US and international regulatory oversight bodies
31(6)
2 Institutional review boards (IRBs), single IRBs and other ethics research review bodies and committees
37(5)
3 Variability across IRBs and other reviewing bodies: Those that exist and those of the future
42(3)
4 Project assurances
45(2)
5 Initial approval and continuing reviews
47(1)
6 Data monitoring committees
48(1)
7 Radiation safety committees
48(2)
8 Disclosure and minimization of conflicts of interest: Personal and institutional
50(3)
Section B Preparing the protocol
4 Designing a clinical research study
53(24)
1 Shaping the study question or hypothesis
53(2)
2 Selecting the study design
55(7)
3 General design characteristics
62(10)
4 Beginning to write the protocol
72(5)
5 Selecting the research population for a clinical study
77(38)
1 Study population: Healthy participants or patient participants?
79(1)
2 Vulnerable subject populations: Who is classified as vulnerable and how this decision is made
80(2)
3 Special populations and additional protections
82(30)
4 Writing the protocol section on study population selection
112(3)
6 Risks and benefits in clinical research
115(26)
1 Weighing risk of harm against potential for benefits
116(8)
2 Regulatory requirements for minimization of risk
124(1)
3 Study procedures for minimization of risk
125(5)
4 Completion of a study
130(2)
5 Research-related injuries
132(1)
6 Maximizing benefits
133(3)
7 Risks of not conducting longitudinal studies
136(1)
8 Writing the protocol section on risk, burden, and discomfort
137(1)
9 Writing the protocol section on benefits
138(3)
7 Recruiting research participants
141(8)
1 Who is responsible for recruiting research participants?
142(2)
2 When does the recruitment process begin and end?
144(2)
3 Recruiting research participants for multiple studies
146(1)
4 The professional research participant
147(1)
5 Writing the protocol section on recruitment
148(1)
8 Informed consent
149(40)
1 Traditions and purpose of informed consent
149(2)
2 When does the informed consent process begin?
151(3)
3 The difference between process and product
154(1)
4 Required elements
155(13)
5 Obtaining valid informed consent
168(5)
6 Writing the protocol section on consent, assent, and surrogacy permissions
173(7)
7 Writing consent, assent, and surrogacy permission documents
180(9)
9 Privacy and confidentiality
189(18)
1 Traditions and expectations
189(2)
2 Management of participant privacy and protection of confidential information
191(2)
3 Provision to the participant of clinically relevant private research information
193(5)
4 Withholding personal information from a study participant
198(4)
5 Provision of information at study conclusion
202(1)
6 Release of research information to others
203(1)
7 Certificate of confidentiality
204(1)
8 Writing the protocol section on privacy and confidentiality
205(1)
9 Writing privacy and confidentiality statements in consent forms
205(2)
10 The "Ethics" section
207(10)
1 The difference between an ethics section and a regulatory compliance section
207(2)
2 An existing model of a substantive ethics section
209(1)
3 Writing a substantive ethics section
210(7)
Section C Procedures, methods, statistics, data management, and record keeping
11 Methods and procedures
217(22)
1 Randomization
217(1)
2 Blinding
218(1)
3 Drug testing
219(7)
4 Surgical trials
226(3)
5 Device testing
229(1)
6 Assessments
230(3)
7 Laboratory studies
233(1)
8 Observational methodologies
233(1)
9 Video and/or audio taping
234(1)
10 Quality-of-life measurements
235(1)
11 Follow-up procedures
236(1)
12 Adverse reactions and adverse events
237(2)
12 Statistics, data collection and management, and record keeping
239(18)
1 Statistics
239(8)
2 Data collection and management
247(5)
3 Record keeping
252(5)
Section D Special ethical issues
13 Use of human biological materials
257(14)
1 Anonymous, anonymized, coded, and identifiable specimens
258(2)
2 Anticipated present and future use(s) of tissue
260(5)
3 Tissue samples from those who are deceased
265(2)
4 Writing the protocol sections on the use and storage of human biological materials
267(4)
14 Special issues raised by evolving areas of clinical research
271(28)
1 Genetics research
271(9)
2 Biologies
280(1)
3 Vaccine trials
281(1)
4 Psychiatric research
282(1)
5 Capacity to give consent: Adults
283(2)
6 Minors
285(1)
7 Recruitment and retention of women, minorities, and other vulnerable and/or potentially vulnerable populations
286(2)
8 Involvement of pregnant women or fetuses
288(1)
9 Community-based participatory research
289(1)
10 Surgical research
290(1)
11 Emergency medicine research
291(3)
12 Prisoners
294(1)
13 Epidemiological research
294(1)
14 Translational research
295(1)
15 Quality assurance and quality improvement research
296(2)
16 Bioterrorism
298(1)
15 Cautionary tales: Learning from experience
299(12)
1 Cases histories from the contemporary to the classical in clinical research ethics
300(11)
Glossary 311(8)
References 319(26)
Index 345
Evan DeRenzo works in the Center for Ethics at Washington Hospital Center, Washington, DC, USA Eric Singer works at the Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA National Institutes of Health, Bethesda, MD, USA